Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser

Andersen R, Wulff Westergaard MC, Westerlin Kjeldsen J, Mueller A, Wulff Pedersen N, Reker Hadrup S, Met O, Seliger B, Kromann-Andersen B, Hasselager T, Donia M, Svane IM. T cell responses in the microenvironment of primary renal cell carcinoma - Implications for adoptive cell therapy. Cancer Immunol Res. 2018 Jan 4. pii: canimm.0467.2017. doi: 10.1158/2326-6066.CIR-17-0467. [Epub ahead of print]

 

Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Immunity. 2018 Jan 4. pii: S1074-7613(17)30536-8. doi: 10.1016/j.immuni.2017.12.007. [Epub ahead of print]

 

Subbarayan K, Leisz S, Wickenhauser C, Bethmann D, Massa C, Steven A, Seliger B. Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. Oncoimmunology. 2018 Jan 16;7(4):e1373233. doi: 10.1080/2162402X.2017.1373233.

 

Steven A., Seliger B. The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer. Breast Care (Basel). 2018 Mar;13(1):16-21. doi: 10.1159/000486585. 

 

Seliger B. Immunotherapy of Breast Cancer. Breast Care (Basel). 2018 Mar;13(1):5-6. doi: 10.1159/000486927. Epub 2018 Feb 13.

 

Polovic M, Dittmar S, Hennemeier I, Humpf HU, Seliger B, Fornara P, Theil G, Azinovic P, Nolze A, Köhn M, Schwerdt G, Gekle M. Cell Mol Life Sci.  2018 Jun;75(12):2241-2256. doi: 10.1007/s00018-017-2731-6. Epub 2017 Dec 27.

 

 

Subbarayan K, Seliger B. Tumor-dependent effects of proteoglycans and various glycosaminoglycan synthesizing enzymes and sulfotransferases on patients' outcome. Curr Cancer Drug Targets. 2018 Jul 6. doi: 10.2174/1568009618666180706165845. [Epub ahead of print]

 

Grünberg M, Quandt D, Cynis H, Demuth HU, Kinderman A, Magdolen V, Forssmann WG, Seliger B, Mägert HJ. Kallikrein-related peptidases are activators of the CC chemokine CCL14. Eur J Immunol. 2018 Jul 20. doi: 10.1002/eji.201747452. 

 

Steven A, Leisz S, Fussek S, Nowroozizadeh B, Huang J, Branstetter D, Dougall WC, Burchardt M, Belldegrun AS, Seliger B, Pantuck A, Kroeger N. Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma. Urol Oncol. 2018 Aug 28. pii: S1078-1439(18)30268-0. doi: 10.1016/j.urolonc.2018.07.013. [Epub ahead of print]